These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? Seferian A; Simonneau G Eur Respir Rev; 2013 Sep; 22(129):217-26. PubMed ID: 23997048 [TBL] [Abstract][Full Text] [Related]
8. Chronic post-embolic pulmonary hypertension: a new target for medical therapies? Delcroix M Eur Respir Rev; 2013 Sep; 22(129):258-64. PubMed ID: 23997053 [TBL] [Abstract][Full Text] [Related]
12. Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy? Correale M; Montrone D; Ieva R; Di Biase M; Brunetti ND Clin Res Cardiol; 2013 May; 102(5):391-3. PubMed ID: 23389056 [No Abstract] [Full Text] [Related]
14. Thrombocytopenia During Prostacyclin Analogue Therapies of Pulmonary Arterial Hypertension-Possible Pathomechanisms and Implications. Grześk G; Karasek D; Kusiak M J Cardiovasc Pharmacol; 2020 May; 75(5):421-425. PubMed ID: 32379109 [TBL] [Abstract][Full Text] [Related]
15. Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation. Vionnet J; Yerly P; Aubert JD; Pascual M; Aldenkortt F; Berney T; Giostra E; Moradpour D; Schiffer E Transplantation; 2018 May; 102(5):e194. PubMed ID: 29485510 [No Abstract] [Full Text] [Related]
16. Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand? Correale M; Ferraretti A; Monaco I; Grazioli D; Di Biase M; Brunetti ND Vasc Health Risk Manag; 2018; 14():253-264. PubMed ID: 30323613 [TBL] [Abstract][Full Text] [Related]
18. Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies. Hansen T; Galougahi KK; Celermajer D; Rasko N; Tang O; Bubb KJ; Figtree G Pharmacol Ther; 2016 Sep; 165():50-62. PubMed ID: 27216365 [TBL] [Abstract][Full Text] [Related]
19. Use of Treprostinil in Pediatric Pulmonary Hypertension: Case Reports and Review of the Literature. Gavotto A; Thomas F; Werner O; Moreau J; Amedro P J Cardiovasc Pharmacol; 2020 Jul; 76(1):23-31. PubMed ID: 32168152 [TBL] [Abstract][Full Text] [Related]
20. An evidence-based approach to the management of pulmonary arterial hypertension. Archer SL; Michelakis ED Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]